VIM-4 carbapenemase-producing Enterobacter cloacae in the United Arab Emirates  by Sonnevend, A. et al.
VIM-4 carbapenemase-producing
Enterobacter cloacae in the United Arab
Emirates
A´. Sonnevend1, A. Ghazawi1, N. Yahfoufi1, A. Al-Baloushi1,
R. Hashmey2, M. Mathew2, W. Z. Tariq2 and T. Pa´l1
1) Department of Microbiology and Immunology, College of Medicine and
Health Sciences, United Arab Emirates University, Al Ain and
2) Tawam Hospital, Al Ain, United Arab Emirates
Abstract
Screening 34 carbapenem non-susceptible Enterobacteriaceae
recovered in Abu Dhabi hospitals identified an Enterobacter cloa-
cae strain carrying blaVIM-4, blaCMY-4 and blaCTX-M-15. It was iso-
lated from the urine of an Egyptian patient repeatedly
hospitalized and treated with broad-spectrum antibiotics, includ-
ing carbapenems, in the United Arab Emirates. The blaVIM-4 cod-
ing class I integron, highly similar to In416, was carried on a
175-kilobase non-conjugative incA/C type plasmid also hybridiz-
ing with the blaCMY-4 probe. This is the first detailed report on
the isolation of a Verona integron-encoded metallo-b-lactamase
(VIM) -producing enteric bacterium in the Arabian Peninsula
with characteristics suggestive of spreading from the Mediterra-
nean region.
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Enteric bacteria producing acquired carbapenemases have
been increasingly reported worldwide. Verona integron-
encoded metallo-b-lactamase (VIM) -producing Enterobacte-
riaceae have been isolated in several countries with high
prevalence noted in the Mediterranean region [1]. The
expression of blaVIM genes confers resistance to all b-lactams
except aztreonam. The single amino acid variant of the first
reported VIM-1 enzyme, VIM-4 was described in a Pseudomo-
nas aeruginosa strain isolated in Greece in 2002 [2]. Subse-
quently, VIM-4 has been identified in Klebsiella pneumoniae,
Enterobacter cloacae, Acinetobacter spp., Aeromonas hydrophyla
and Escherichia coli [3–9]. VIM-4-producing Enterobacteria-
ceae strains reportedly also harboured various other b-lacta-
mases, e.g. KPC-2 [6], CMY-4 [10,11], CTX-M-15 [8,10],
SHV-12 [3], SHV-2a [4] and TEM-1 [10], respectively. The
blaVIM-4 gene has been described exclusively as part of a class
I integron located, in most of the cases, on conjugative plas-
mids of varying size, which, if tested, all belonged to the A/C
incompatibility group (summarized in Table 1).
The VIM-type metallo-b-lactamase-producing bacteria are
rarely described from the Arabian Peninsula. Acinetobacter
baumannii and P. aeruginosa producing VIM-2 were reported
from Kuwait and Saudi Arabia [12,13]. However, at the time
of writing, a search of the literature did not reveal any
description of VIM-producing Enterobacteriaceae from the
Gulf region, beyond a conference abstract from Kuwait [14].
Here we report on the isolation and first detailed analysis of
a VIM-producing enteric bacterium from the Arabian Penin-
sula, an Enterobacter cloacae strain carrying the blaVIM-4 gene.
Screening 34 carbapenem non-susceptible clinical Entero-
bacteriaceae strains isolated in Abu Dhabi Emirate by a mul-
tiplex PCR [15] identified known carbapenemase genes in 22
isolates. blaNDM was found in six K. pneumoniae, one E. cloa-
cae, two Escherichia coli and one Citrobacter freundii, while
blaOXA-48-like was identified in eight K. pneumoniae and three
Escherichia coli strains, respectively. An E. cloacae strain posi-
tive for blaVIM (ABC104) was also identified. This strain was
isolated in January 2012 from the urine sample of a 45-year-
old Egyptian male, permanent resident of the United Arab
Emirates. The man had a spinal cord injury and urinary
incontinence since the age of 12 years. Two years before
sampling the patient had stayed in Egypt for a short while on
family business, but he had never received any medical treat-
ment beyond the United Arab Emirates. He was diagnosed
with lumbosacral ependymoma in 2009 and underwent sub-
total excision of the mass in June 2011. Because of residual
tumour, the surgical wound never healed and was secondar-
ily infected. Superficial wound cultures grew K. pneumoniae,
methicillin-resistant Staphylococcus aureus and normal skin
flora. Over the ensuing months, he was treated with multiple
courses of intravenous and oral antibiotics including pipera-
cillin–tazobactam, ertapenem, meropenem, amoxicillin–clavul-
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anate and levofloxacin for a cumulative total of 138 Defined
Daily Doses. In January 2012, he was admitted with back
pain and cloudy urine.
The ABC104 strain was resistant to imipenem (MIC =
16 mg/L), meropenem (MIC = 8 mg/L), ertapenem (MIC = 4
mg/L), ceftazidime (MIC >128 mg/L), cefotaxim (MIC >128
mg/L), cefepime (MIC = 64 mg/L), aztreonam (MIC >128 mg/
L), cefoperazone (MIC = 64 mg/L), trimethoprim/sulpha-
methoxazole (MIC = 8/76 mg/L), chloramphenicol (MIC =
32 mg/L), gentamicin (MIC = 32 mg/L), tobramycin
(MIC = 48 mg/L), netilmicin (MIC = 32 mg/L), ciprofloxacin (MIC
= 32 mg/L), moxifloxacin (MIC = 12 mg/L), levofloxacin
(MIC = 12 mg/L), tetracycline (MIC = 64 mg/L) and minocy-
cline (MIC = 32 mg/L) and exhibited sensitivity to amikacin
(MIC = 6 mg/L) and colistin (MIC = 0.125 mg/L), only as
tested by microdilution according to the CLSI standards
[16]. It carried the blaVIM-4 gene on an incA/C type [17] plas-
mid of c.175 kilobases as detected by Southern blotting of
the S1-digested genomic DNA (Fig. 1). Attempts to conju-
gally transfer the plasmid into an azid-resistant derivative of
Escherichia coli J53 failed at 30C, as well as at 37C. By PCR
mapping and sequencing using primers designed based on
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FIG. 1. Southern blot of Enterobacter cloacae strain ABC104 S1-
digested genomic DNA. Gel, left lane: k concatamer. Oligonucleotide
probes of the respective genes (see above the membrane strips)
were PCR-generated and labelled with a DIG-DNA labelling kit
(Roche Diagnostics GmbH, Mannheim, Germany). After hybridization
and colour development the probe was removed and the membrane
was re-hybridized with the next probe. Detection was achieved by
an alkaline-phosphatase-based reaction according to the manufac-
turer’s instructions.
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previously published sequences (GenBank accession numbers.
AJ704863 and AY339625) the blaVIM-4 gene was identified as
part of a class I integron (Table 1). The integron was similar
to other blaVIM-4-containing integrons identified in various
Enterobacteriaceae isolates in Italy, Russia, Tunisia and
Greece (Table 1) [4,8,10,11]. However, unlike in the Italian
isolate VA-416/02 [11], in ABC104 the conserved 3¢ end of
the class 1 integron was identified downstream of the ISPa21
(GenBank accession number JX27577). ABC104 also har-
boured other b-lactamase genes: blaCTX-M-15, blaTEM-1 and
blaCMY-4; blaCMY-4 being localized on the same plasmid as
blaVIM-4 by Southern blotting. The blaCTX-M-15 gene was
carried on a plasmid of c.300 kilobases, whereas a probe for
blaTEM-1 hybridized with both plasmids (Fig. 1).
This first description of a VIM-4-producing enteric bacte-
rium in the Arabian Peninsula adds a further resistance
mechanism to the list of carbapenemases, mostly of the
NDM and OXA-types, in Enterobacteriaceae already
reported from the region [18–20]. The nationality and travel
history of the patient, and the fact that the other b-lactamas-
es, the plasmid, and the class I integron containing the blaVIM-
4 of ABC104 were all highly similar to those previously
described from Italy [11] and North Africa [10] suggests the
possibility of these resistance genes, or the organism itself,
spreading from the Mediterranean region to the Gulf.
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